publication date: Dec. 18, 2010

In this issue: 

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors. 

Compendium Drops Listing of Aranesp for Anemia of Cancer.

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

Download (PDF 782KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.